6.36
0.32%
0.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LFMD Giù?
Forum
Previsione
Frazionamento azionario
Lifemd Inc Borsa (LFMD) Ultime notizie
LifeMD, Inc. (NASDAQ:LFMD) Given Consensus Rating of "Buy" by Analysts - MarketBeat
(LFMD) Technical Data - Stock Traders Daily
Royce & Associates LP Boosts Stock Holdings in LifeMD, Inc. (NASDAQ:LFMD) - MarketBeat
LifeMD (NASDAQ:LFMDP) Stock Price Down 1.1% – Should You Sell? - Defense World
LifeMD, Inc. (NASDAQ:LFMD) Shares Bought by Los Angeles Capital Management LLC - MarketBeat
LifeMD (LFMD) to Present at Three Major Healthcare Investor Conferences in November | LFMDP Stock News - StockTitan
LifeMD to Participate in Three Investor Conferences During November - The Manila Times
LifeMD (LFMD) to Present at Three Major Healthcare Investor Conferences in November | LFMD Stock News - StockTitan
LifeMD Inc (NASDAQ: LFMD) Could Pass $12 In One Year Stock Forecast - Stocks Register
HC Wainwright Reiterates Buy Rating for LifeMD (NASDAQ:LFMD) - MarketBeat
LifeMD, Inc. (NASDAQ:LFMD) Q3 2024 Earnings Call Transcript - Insider Monkey
LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 31% Yet They're Still Not Telling The Full Story - Simply Wall St
LifeMD Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
(LFMD) Technical Pivots with Risk Controls - Stock Traders Daily
LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Teleh - GuruFocus.com
LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance
LifeMD, Inc. (LFMD) Reports Q3 Loss, Lags Revenue Estimates - MSN
LifeMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
LifeMD Reports Third Quarter 2024 Results - The Manila Times
LifeMD earnings beat by $0.21, revenue fell short of estimates - Investing.com UK
Institutions profited after LifeMD, Inc.'s (NASDAQ:LFMD) market cap rose US$39m last week but individual investors profited the most - Simply Wall St
Earnings to Watch: LifeMD Inc (LFMD) Reports Q3 2024 Result - GuruFocus.com
LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency - The Manila Times
Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) Target Price at $12.00 - Defense World
Medifast Announces Third Quarter 2024 Financial Results - StockTitan
LifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Buy" by Brokerages - MarketBeat
LifeMD announces board member resignation By Investing.com - Investing.com Australia
LifeMD announces board member resignation - Investing.com India
LifeMD stock touches 52-week low at $4.03 amid market challenges - Investing.com Canada
LifeMD (LFMD) Set to Announce Earnings on Thursday - MarketBeat
LifeMD Shares Decline Even After the Launch of Testosterone Therapy - MSN
LifeMD® To Report Third Quarter 2024 Financial Results On November 7 - Barchart
LifeMD launches TestoRx, direct to consumer testosterone replacement therapy - Yahoo Finance
LifeMD® to Report Third Quarter 2024 Financial Results on November 7 - GlobeNewswire
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer - GlobeNewswire
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering - Yahoo Finance
The Manufacturers Life Insurance Company Purchases Shares of 13,551 LifeMD, Inc. (NASDAQ:LFMD) - Defense World
Trading Day Review: LifeMD Inc (LFMD) Gains Momentum, Closing at 4.64 - The Dwinnex
LifeMD shares hold as BTIG maintains $12 target By Investing.com - Investing.com Australia
LifeMD shares hold as BTIG maintains $12 target - Investing.com
Is it possible to buy LifeMD Inc(LFMD) shares at a good price now? - US Post News
LifeMD, Inc.'s (NASDAQ:LFMD) top owners are retail investors with 45% stake, while 38% is held by institutions - Yahoo Finance
LifeMD Inc [LFMD] stock for 14,790 USD was bought by Galluppi Stefan - Knox Daily
LifeMD Inc (LFMD) Stock: A Year of Declines and Increases - The InvestChronicle
Financial Health Check: Examining LifeMD Inc (LFMD)’s Key Ratios - The Dwinnex
LifeMD shares maintain Buy rating from B.Riley amid market demand By Investing.com - Investing.com South Africa
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):